Article Details
Retrieved on: 2024-05-16 01:32:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AYTU stock results show that Aytu BioPharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Article found on: investorplace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here